CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.24, ss.580-583, 2006 (SCI İndekslerine Giren Dergi)
Objectives. Recent studies support an inflammatory basis for atherosclerosis. Patients with chronic inflammatory rheumatical disorders are at increased risk for cardiovascular events, and this can be partially attributed to the inhibition of fibrinolytic system. TNF alpha inhibitors such as.infliximab are shown to retard the progression of inflammatory arthritides. In this study, we investigated the effects of infliximab on plasma fibrinolytic parameters.